Indication
Prevention of COVID-19.
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
COVID-19 virus infection
Marketing Authorisation Holder: AstraZeneca AB
EMA Authorisation: 25/03/2022
INN: tixagevimab;cilgavimab
AI Drug & Interaction Analysis
Free account required
Ask Osler about Evusheld: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.